The prognosis impact of BCR-ABL P-loop mutations: worse or not worse?

F E Nicolini; S Corm; Q-H Lê; C Roche-Lestienne; C Preudhomme

首页> 外文期刊>Leukemia >The prognosis impact of BCR-ABL P-loop mutations: worse or not worse?

【24h】

The prognosis impact of BCR-ABL P-loop mutations: worse or not worse?

机译：BCR-ABL P环突变对预后的影响：更糟还是更糟？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia》 |2007年第2期|共2页
作者
F E Nicolini; S Corm; Q-H Lê; C Roche-Lestienne; C Preudhomme;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders [J] . Gao Li-Min, Zhao Sha, Zhang Wen-Yan, Cancer biology & therapy . 2019,第10a12期

机译：KMT2D和TET2的体细胞突变与综合症 - 巴克病毒相关的T或天然杀伤细胞淋巴抑制性疾病更差的预后
2. NOTCH1 mutations Identify a chronielymphocytic leukeima patient subset with worse prognosis in tie setting of a rituximab-based induction and consolidation treatment [J] . Michele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, Annals of hematology . 2014,第10期

机译：NOTCH1突变鉴定出基于利妥昔单抗的诱导和巩固治疗的预后较差的慢性淋巴细胞性白血病患者亚群
3. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma [J] . SinnB.V., StrieflerJ.K., RudlM.A., Pancreas . 2014,第4期

机译：12或13位密码子的KRAS突变与胰腺导管腺癌预后较差有关
4. When the cure is worse than the disease: The impact of graceful IGP operations on BGP [C] . Vanbever Laurent, Vissicchio Stefano, Cittadini Luca, IEEE INFOCOM . 2013

机译：当治愈方法胜于疾病时：优雅的IGP操作对BGP的影响
5. Calcium Stress in Daphnia Pulicaria and Exposure to Predator-Derived Cues: Making a Bad Situation Worse? [D] . Rice, Marcus James. 2021

机译：Daphnia puricaria的钙胁迫和暴露于捕食者衍生的线索：使情况变得更糟？
6. Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis [O] . Adi Zundelevich, Maya Dadiani, Smadar Kahana-Edwin, 2020

机译：校正至：ESR1突变在新诊断为内分泌治疗的乳腺癌的转移和局部复发中很常见预后更差
7. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis [O] . Branford S., Rudzki Z., Walsh S., 2003

机译：用伊马替尼治疗的CmL患者中BCR-aBL突变的检测实际上总是伴有临床耐药性，aTp磷酸盐结合环（p环）的突变与预后不良有关

The prognosis impact of BCR-ABL P-loop mutations: worse or not worse?

著录项

相似文献

相关主题

期刊订阅